Unlocking revenue through Gross-to-Net excellence in Pharma

EU JCA: From regulation to real-life impact on price, access & time-to-reimbursement

Nathan Swilling

Dr. Nathan Swilling is a Senior Partner and Co-Head of the global Pharma & Biotech practice within Simon-Kucher's Life Sciences activities in Boston. Since joining the company in 2004, he has specialized in strategic marketing, access planning, pricing, and reimbursement of pharmaceuticals and biotech products.

Madhavan Ramanujam

Rowan Conway

<p>Rowan Conway is Founder, Transformation by Design Ltd and Visiting Professor of Strategic Design at the UCL Institute for Innovation and Public Purpose, as well as Associate Lecturer, Net Zero Scenarios, UCL School of Management and Associate Lecturer, Public Entrepreneurship, Blavatnik School of Management at Oxford University. Rowan is also a Non-Executive Director, Live Work service design agency.</p>

Simon-Kucher Prolongationsstudie 2025 | Was Regionalbanken zu Anschlussfinanzierungen jetzt wissen müssen!

Beating Revenue Targets in Uncertain Times

Marilyn Sarkis

7th Houston Strategy & Pricing Forum: The Future of Pricing – Strategies for Sustainability and Innovation

Alix Nepveux

Alix Nepveux is a Partner at the Paris office and a member of the global Software, Internet, & Technology practice. She primarily supports B2B software companies and online booking platforms and marketplaces.